Search
Business Practice
View More
Business
Development
Legal
Policy
Practice
Regulatory
Business
Development
Legal
Policy
Practice
Regulatory
News
Media
All Videos
Insights
Interviews
Peer Exchange
Podcasts
All Videos
Insights
Interviews
Peer Exchange
Podcasts
Clinical
Dermatology
Endocrinology
Gastroenterology
Legal
Neurology
Oncology
Ophthalmology
Rare Disease
Rheumatology
Dermatology
Endocrinology
Gastroenterology
Legal
Neurology
Oncology
Ophthalmology
Rare Disease
Rheumatology
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
CME/CE
Resources
Authors
Biosimilar Resources
Polls
Authors
Biosimilar Resources
Polls
Subscribe
Search
Business Practice
See All >
Business
Development
Legal
Policy
Practice
Regulatory
Regulation, Policy, and Litigation in Biosimilars
EP 1: Biosimilar Interchangeability and Market Share
EP 2: Interchangeability and Rheumatology Prescribing Practices
EP 3: Biosimilars, Interchangeability, and Perceptions of Safety
EP 4: Global Reference Products in Biosimilar Development
EP 5: Inspection Reports and Proprietary Information
EP 6: Reforms at the FDA Level
EP 7: Biosimilars, Formularies, Contracting, and PBMs
EP 8: Biosimilar Uptake and Health Plans
EP 9: CMS and Blended Reimbursement Codes
EP 10: Healthcare Reform Efforts and the BPCIA
EP 11: State Laws and Biosimilar Substitution
EP 12: The PTAB's Role in Biosimilar Patent Disputes
EP 13: The Need for Clarity After
Sandoz v Amgen
EP 14: Upcoming Patent Litigation in Biosimilars
EP 15: Challenges Ahead for Biosimilars
Next >>